O27 Vacuum-photon-magnetic massagers oF V. Korobov A. Korobov “Barva-Pneumo/FM”

Observation of the 1154.9 nm transition of antiprotonic helium

“…This value was in good agreement with the decay rate of 0.52 ± 0.18 µs −1 [7] which was indirectly estimated from previous studies on the lower-lying state (39,35). The radiative decay rate of the state (40,36) has been theoretically calculated as 0.55 µs −1 [34] and 0.47 µs −1 [25]. The former theoretical value was slightly larger than λ exp , while the latter is in good agreement with λ exp .…”

Bounding quantum dark forces

“…In all cases but for the ðν ¼ 1; J ¼ 0Þ states of ddμ þ , the wave function at small r is so small that it is neglected-and its value is even difficult to obtain numerically [51,53]. On the other hand for ddμ þ the tail at small r is not negligible.…”

“…At small r, the wave functions of these states are constant except for ddμ þ which behaves as ∼r [53]. In all cases but for the ðν ¼ 1; J ¼ 0Þ states of ddμ þ , the wave function at small r is so small that it is neglected-and its value is even difficult to obtain numerically [51,53].…”

Myocardial resistance to ischemic and reperfusion injuries under conditions of chronic administration of opioid receptor agonists and antagonists

“…The animals received μ-, δ-, and κ-OR agonist dalargin (D-Ala 2 ,Leu 5 ,Arg 6 -encephalin) intraperitoneally in a dose of 1 mg/kg (n=15) [2,3]; κ 2 -OR agonist GR 89696 subcutaneously in a dose of 0.03 mg/kg (n=16) [6]; or nonselective nonpeptide OR antagonist quadazocine subcutaneously in a dose of 3 mg/kg (n=13) [8,10] for 20 days. The dose of nonselective OR antagonist naltrexone (10 mg/kg, subcutaneously, n=15) was chosen experimentally by the capacity of this agent to prevent the chronoropic effect of U-50488 (selective κ-OR agonist).…”